141 related articles for article (PubMed ID: 17518043)
1. [Evolutionary trace analysis of N-myristoyltransferase family].
Sheng CQ; Zhu J; Zhang WN; Xu H; Miao ZY; Yao JZ; Zhang M
Yao Xue Xue Bao; 2007 Feb; 42(2):157-65. PubMed ID: 17518043
[TBL] [Abstract][Full Text] [Related]
2. Conserved residues and their role in the structure, function, and stability of acyl-coenzyme A binding protein.
Kragelund BB; Poulsen K; Andersen KV; Baldursson T; Krøll JB; Neergård TB; Jepsen J; Roepstorff P; Kristiansen K; Poulsen FM; Knudsen J
Biochemistry; 1999 Feb; 38(8):2386-94. PubMed ID: 10029532
[TBL] [Abstract][Full Text] [Related]
3. Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-based inhibitors of human N-myristoyltransferase-1.
French KJ; Zhuang Y; Schrecengost RS; Copper JE; Xia Z; Smith CD
J Pharmacol Exp Ther; 2004 Apr; 309(1):340-7. PubMed ID: 14724220
[TBL] [Abstract][Full Text] [Related]
4. Myristoyl-CoA:protein N-myristoyltransferases: isoform identification and gene expression in retina.
Rundle DR; Rajala RV; Alvarez RA; Anderson RE
Mol Vis; 2004 Mar; 10():177-85. PubMed ID: 15041955
[TBL] [Abstract][Full Text] [Related]
5. Structure of N-myristoyltransferase from Aspergillus fumigatus.
Shimada T; Suzuki M; Katakura S
Acta Crystallogr D Biol Crystallogr; 2015 Apr; 71(Pt 4):754-61. PubMed ID: 25849386
[TBL] [Abstract][Full Text] [Related]
6. Structure of N-myristoyltransferase with bound myristoylCoA and peptide substrate analogs.
Bhatnagar RS; Fütterer K; Farazi TA; Korolev S; Murray CL; Jackson-Machelski E; Gokel GW; Gordon JI; Waksman G
Nat Struct Biol; 1998 Dec; 5(12):1091-7. PubMed ID: 9846880
[TBL] [Abstract][Full Text] [Related]
7. Evolutionary trace analysis of the Kunitz/BPTI family of proteins: functional divergence may have been based on conformational adjustment.
Pritchard L; Dufton MJ
J Mol Biol; 1999 Jan; 285(4):1589-607. PubMed ID: 9917399
[TBL] [Abstract][Full Text] [Related]
8. Effects of L-histidine and its structural analogues on human N-myristoyltransferase activity and importance of EEVEH amino acid sequence for enzyme activity.
Raju RV; Datla RS; Warrington RC; Sharma RK
Biochemistry; 1998 Oct; 37(42):14928-36. PubMed ID: 9778369
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and antifungal activity of isosteric analogues of benzoheterocyclic N-myristoyltransferase inhibitors.
Sheng C; Xu H; Wang W; Cao Y; Dong G; Wang S; Che X; Ji H; Miao Z; Yao J; Zhang W
Eur J Med Chem; 2010 Sep; 45(9):3531-40. PubMed ID: 20615585
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of Saccharomyces cerevisiae N-myristoyltransferase with bound myristoyl-CoA and inhibitors reveal the functional roles of the N-terminal region.
Wu J; Tao Y; Zhang M; Howard MH; Gutteridge S; Ding J
J Biol Chem; 2007 Jul; 282(30):22185-94. PubMed ID: 17513302
[TBL] [Abstract][Full Text] [Related]
11. Potent inhibitor of N-myristoylation: a novel molecular target for cancer.
Shrivastav A; Pasha MK; Selvakumar P; Gowda S; Olson DJ; Ross AR; Dimmock JR; Sharma RK
Cancer Res; 2003 Nov; 63(22):7975-8. PubMed ID: 14633729
[TBL] [Abstract][Full Text] [Related]
12. Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.
Sikorski JA; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Nagarajan S; Mehta PP; Wade AC; Kishore NS; Bryant ML; Getman DP; McWherter CA; Gordon JI
Biopolymers; 1997; 43(1):43-71. PubMed ID: 9174411
[TBL] [Abstract][Full Text] [Related]
13. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design.
Sheng C; Ji H; Miao Z; Che X; Yao J; Wang W; Dong G; Guo W; Lü J; Zhang W
J Comput Aided Mol Des; 2009 Jun; 23(6):375-89. PubMed ID: 19370313
[TBL] [Abstract][Full Text] [Related]
14. Active site residues governing substrate selectivity and polyketide chain length in aloesone synthase.
Abe I; Watanabe T; Lou W; Noguchi H
FEBS J; 2006 Jan; 273(1):208-18. PubMed ID: 16367761
[TBL] [Abstract][Full Text] [Related]
15. A continuous fluorometric assay of myristoyl-coenzyme A:protein N-myristoyltransferase.
Pennise CR; Georgopapadakou NH; Collins RD; Graciani NR; Pompliano DL
Anal Biochem; 2002 Jan; 300(2):275-7. PubMed ID: 11779123
[No Abstract] [Full Text] [Related]
16. N-myristoyltransferase from Leishmania donovani: structural and functional characterisation of a potential drug target for visceral leishmaniasis.
Brannigan JA; Smith BA; Yu Z; Brzozowski AM; Hodgkinson MR; Maroof A; Price HP; Meier F; Leatherbarrow RJ; Tate EW; Smith DF; Wilkinson AJ
J Mol Biol; 2010 Mar; 396(4):985-99. PubMed ID: 20036251
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of myristoyl CoA analogues and myristoyl peptides as inhibitors of myristoyl CoA:protein N-myristoyltransferase.
Zheng GQ; Hu X; Cassady JM; Paige LA; Geahlen RL
J Pharm Sci; 1994 Feb; 83(2):233-8. PubMed ID: 8169796
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary identification of a subtype specific functional site in the ligand binding domain of steroid receptors.
Raviscioni M; He Q; Salicru EM; Smith CL; Lichtarge O
Proteins; 2006 Sep; 64(4):1046-57. PubMed ID: 16835908
[TBL] [Abstract][Full Text] [Related]
19. Myristoyl CoA:protein N-myristoyltransferase: subcellular localization, activation and kinetic behavior in the presence of organic solvents.
Rajala RV; Sharma RK
Biochem Biophys Res Commun; 1995 Mar; 208(2):617-23. PubMed ID: 7695615
[TBL] [Abstract][Full Text] [Related]
20. Crystal structures of Candida albicans N-myristoyltransferase with two distinct inhibitors.
Sogabe S; Masubuchi M; Sakata K; Fukami TA; Morikami K; Shiratori Y; Ebiike H; Kawasaki K; Aoki Y; Shimma N; D'Arcy A; Winkler FK; Banner DW; Ohtsuka T
Chem Biol; 2002 Oct; 9(10):1119-28. PubMed ID: 12401496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
